Chargement des cours...
Prévisions
| Acheter |
1 |
| Conserver |
0 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
Inspira Technologies wins $596,000 order for AME system from Irish research university
Inspira Technologies has secured a $596,000 order for an AME system (additive manufacturing of electronics) from an Irish technological research university. The company received a non‑refundable 40% advance payment, with the remainder due on delivery. The order includes recurring revenue from consumables, wear parts and annual service fees; delivery, installation and training are planned in the coming weeks and are intended to serve as a reference for further academic and commercial collaborations in Europe. Inspira has a market capitalization of $19.28 million and annual revenue of $290,000. » Plus sur de.investing.com
Inspira Technologies enters quantum computing and plans to rebrand as QTREX
Inspira Technologies announces a strategic entry into the quantum computing sector and aims to use its additively manufactured AME platform to address 3D connectivity issues in dilution cryostats to improve qubit coherence and system stability. The company, led by CEO Dagi Ben-Noon and COO Avi Shabtay, reports a proof of concept for integrating qubit-relevant components and is negotiating partnerships but provides no details or timelines. Inspira plans to continue its medical technology division as a subsidiary, intends to change its name to QTREX, and points to large market forecasts, but remains financially unprofitable and shows high cash outflows. » Plus sur de.investing.com
Inspira Technologies terminates two financing agreements
Inspira Technologies announces the written termination of its sales agreement with A.G.P./Alliance Global Partners dated 17 February 2026 and its standby equity purchase agreement with YA II PN, Ltd. dated 12 December 2025. The company has no outstanding obligations under either agreement and no further payments will be made. Inspira cites the goal of a disciplined capital structure as the reason for the move while it prepares for the next strategic phase; the stock has recently fallen sharply and, according to InvestingPro, is fairly valued. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | juin 2025 | YoY |
|---|---|---|
| Chiffre d'affaires | 122,6 k | - |
| Bénéfice brut | 848,42 | - |
| Bénéfice net | -2,71 M | - |
| EBITDA | -3,04 M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 22,55 M € |
Nombre d'actions | 24,08 M |
Plus haut/bas sur 52 semaines | 1,87 € - 0,30 € |
| Dividendes | Non |
Bêta | 2,33 |
Ratio P/E | - |
Ratio PEG | - |
Ratio P/B | - |
Ratio P/S | - |
Profil de l'entreprise
Inspira Technologies Oxy B.H.N. Ltd., une société spécialisée dans les dispositifs médicaux, se consacre à la recherche, au développement, à la fabrication et à la commercialisation de technologies d'assistance respiratoire destinées à offrir une alternative à la ventilation mécanique invasive (MV) pour le traitement de l'insuffisance respiratoire. Son produit phare est le système de technologie de respiration augmentée (ART), un système d'assistance respiratoire comprenant une canule à double lumière portable et peu invasive, insérée dans la veine jugulaire, qui utilise une oxygénation directe du sang extracorporelle pour élever et stabiliser les niveaux de saturation en oxygène en baisse. La société était auparavant connue sous le nom d'Insense Medical Ltd. et a changé sa dénomination en Inspira Technologies Oxy B.H.N. Ltd. en juillet 2020. La société a été constituée en 2018 et est basée à Ra'annana, en Israël.
| Nom | INSPIRA TECH OXY IS-,125 Aktie |
| PDG | Dagi Shahar Ben-Noon |
| Siège social | Ra'anana,
Israël |
| Site web | |
| Secteur | Consommation discrétionnaire |
| Industrie | Biens de consommation durables |
| Introduction en bourse | 14/07/2021 |
| Employés | 39 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NASDAQ | IINN |